Matsumoto Kazuyuki, Kato Hironari, Fujii Masakuni, Ueki Toru, Saragai Yosuke, Tsugeno Hirofumi, Mannami Tomohiko, Okada Hiroyuki
Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Department of Internal Medicine, Okayama Saiseikai General Hospital, Okayama, Japan.
J Hepatobiliary Pancreat Sci. 2022 Dec;29(12):1300-1307. doi: 10.1002/jhbp.1188. Epub 2022 Jun 22.
Endoscopic fully-covered self-expandable metal stents (FCSEMSs) are used to treat benign biliary strictures (BBSs); however, treatment for perihilar BBSs is technically challenging. The aim of this study was to evaluate the usefulness of an unflared FCSEMS designed for intraductal placement in patients with refractory perihilar BBS.
Twenty-two consecutive patients with perihilar BBS unresolved by endoscopic plastic stent placement at 13 tertiary medical centers were prospectively enrolled. The FCSEMS was placed above the papilla and removed after 4 months. The primary outcome was stricture resolution at 4 months, and the secondary outcomes were technical success, stent removal, adverse events, and recurrence.
The technical success rate of intraductal FCSEMS placement was 100%, and plastic stent placement at contralateral or side branch was performed in 86% of patients. The rate of successful stent removal at 4 months was 100%, and stricture resolution was observed in 91% of patients. Stent migration or stent-induced de novo stricture did not occur in any patient. The stricture recurrence rate was 16%, and the median (interquartile range) follow-up duration was 2.8 (1.6-3.3) years.
Intraductal placement of unflared FCSEMS is effective treatment for refractory perihilar BBS.
内镜全覆膜自膨式金属支架(FCSEMS)用于治疗良性胆管狭窄(BBS);然而,肝门部BBS的治疗在技术上具有挑战性。本研究的目的是评估一种专为肝门部难治性BBS患者导管内放置设计的无喇叭口FCSEMS的有效性。
前瞻性纳入13家三级医疗中心22例经内镜塑料支架置入后仍未解决的肝门部BBS患者。FCSEMS放置在乳头上方,4个月后取出。主要结局是4个月时狭窄缓解,次要结局是技术成功率、支架取出、不良事件和复发。
导管内FCSEMS置入的技术成功率为100%,86%的患者在对侧或侧支进行了塑料支架置入。4个月时支架成功取出率为100%,91%的患者狭窄得到缓解。所有患者均未发生支架移位或支架诱导的新发狭窄。狭窄复发率为16%,中位(四分位间距)随访时间为2.8(1.6 - 3.3)年。
无喇叭口FCSEMS导管内放置是治疗肝门部难治性BBS的有效方法。